Fecal Microbiota Transplantation Improves Cognitive Function of a Mouse Model of Alzheimer's Disease
CNS Neuroscience & Therapeutics · 2025-02 · 31 (2)
DOI: 10.1111/cns.70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 17.02.2025. Verfasst von Xueqin Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Alzheimer Disease, Cognition. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Background
A growing body of evidence suggests a link between the gut microbiota and Alzheimer's disease (AD), although the underlying mechanisms remain elusive. This study aimed to investigate the impact of fecal microbiota transplantation (FMT) on cognitive function in a mouse model of AD.
Methods
Four‐month‐old 5 × FAD (familial Alzheimer's disease) mice underwent antibiotic treatment to deplete their native gut microbiota. Subsequently, they received FMT either weekly or every other day. After 8 weeks, cognitive function and β‐amyloid (Aβ) load were assessed through behavioral testing and pathological analysis, respectively. The composition of the gut microbiota was analyzed using 16S rRNA sequencing.
Results
Initial weekly FMT failed to alleviate memory deficits or reduce brain Aβ pathology in 5 × FAD mice. In contrast, FMT administered every other day effectively restored gut dysbiosis in 5 × FAD mice and decreased Aβ pathology and lipopolysaccharide levels in the colon and hippocampus. Mechanistically, FMT reduced the expression of amyloid β precursor protein, β‐site APP cleaving enzyme 1, and presenilin‐1, potentially by inhibiting the Toll‐like receptor 4/inhibitor of kappa B kinase β/nuclear factor kappa‐B signaling pathway. However, the cognitive benefits of FMT on 5 × FAD mice diminished over time.
Conclusion
These findings demonstrate the dose‐ and time‐dependent efficacy of FMT in mitigating AD‐like pathology, underscoring the potential of targeting the gut microbiota for AD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Jiangsu Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.
- Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Brain Institute, Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, X., Zheng, Y., Sun, H., Dang, Y., Yin, M., Xiao, M., & Wu, T. (2025). Fecal Microbiota Transplantation Improves Cognitive Function of a Mouse Model of Alzheimer's Disease. CNS Neuroscience & Therapeutics, 31(2). https://doi.org/10.1111/cns.70259
Vancouver
Jiang X, Zheng Y, Sun H, Dang Y, Yin M, Xiao M, et al. Fecal Microbiota Transplantation Improves Cognitive Function of a Mouse Model of Alzheimer's Disease. CNS Neuroscience & Therapeutics. 2025;31(2). doi:10.1111/cns.70259
BibTeX
@article{Jiang2025,
author = {Jiang, Xueqin and Zheng, Yu and Sun, Huaiqing and Dang, Yini and Yin, Mengmei and Xiao, Ming and Wu, Ting},
title = {Fecal Microbiota Transplantation Improves Cognitive Function of a Mouse Model of Alzheimer's Disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {2},
doi = {10.1111/cns.70259}
}
EUVIMED